Table 3.

LDH assay of linear and cyclic analogues of carnosine for cell lines HepG2 and HT-29

Entry	Viability percentage (HepG2)	Viability percentage (HT-29)
1b	61.65	20.88
2b	60.98	20.88
3b	20.26	20.43
4b	73.38	11.43
5b	24.25	17.36
6b	84.37	10.7
7b	63.7	83.39
8b	73.19	21.64
1c	10.48	29.01
2c	16.92	71.61
3c	9.92	26.54
4c	84.49	34.26
5-Fu	7.78	6.19
Control	100	100